journal
MENU ▼
Read by QxMD icon Read
search

South Asian Journal of Cancer

journal
https://www.readbyqxmd.com/read/29721485/practical-consensus-recommendations-for-neo-adjuvant-chemotherapy-in-triple-negative-breast-cancer
#1
G S Bhattacharyya, M Walia, M Nandi, A Murli, S Salim, S Rajpurohit, S Shinde, S Aggarwal, P M Parikh
This manuscript provides a practical and easy to use consensus recommendation to community oncologists on how to use neoadjuvant chemotherapy in triple negative breast cancer patients.
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721484/practical-consensus-recommendations-on-ovarian-suppression-in-early-breast-cancer-adjuvant
#2
M Singhal, T P Sahoo, S Aggarwal, A Singhvi, V Kaushal, S Rajpurohit, K M Parthasarthi, A Vora, M Ganvir, S Gupta, Purvish M Parikh
Substantial survival benefits exist for patients with early-stage breast cancer who undergo treatment with single-modality ovarian suppression, but its value is uncertain. Expert oncologist discussed to determine whether additional benefits exist with ovarian suppression plus multiple adjuvant therapy which provides a new treatment option that reduces the risk of recurrence in early breast cancer. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at this practical consensus recommendations for the benefit of community oncologists...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721483/practical-consensus-recommendations-regarding-the-management-of-her2-neu-positive-metastatic-breast-cancer
#3
M Basade, M Singhal, A K Rathi, M Nandi, S Minhas, C Goswami, S Shinde, P M Parikh, S Aggarwal
Metastatic breast cancer (MBC) is cancer that has spread from the breast to another part of the body or has come back in another distant location. Treatment options for MBC depend on several factors, including where the cancer has spread, the patient's overall health, and the levels of hormone receptors and HER2 in the tumour. Over-expression of HER2 is generally considered to be a negative prognostic feature because it accompanies an increase in breast cancer mortality. However, the development of agents that specifically target HER2 has improved the management of patients with these tumours...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721482/practical-consensus-recommendations-on-duration-of-adjuvant-hormonal-therapy-in-breast-cancer
#4
S Gupta, M Singh, Amish Vora, G Babu, M Walia, V Nautial, R Saha, B K Smruti, J B Sharma, R Koul, Purvish M Parikh, S Aggarwal
Optimization of adjuvant systemic therapy in women with early-stage hormone receptor-positive breast cancer includes the consideration of chemotherapy and duration of hormone therapy. Adjuvant hormonal therapy significantly improves long-term survival of breast cancer patients with hormone receptor-positive disease. Despite the proven clinical efficacy of tamoxifen and aromatase inhibitors, many breast cancer survivors either fail to take the correct dosage at the prescribed frequency (adherence) or discontinue therapy (persistence)...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721481/practical-consensus-recommendations-regarding-the-use-of-hormonal-therapy-in-metastatic-breast-cancer
#5
Senthil Rajappa, J Bajpai, M Basade, M Ganvir, C Goswami, A Murali, A K Rathi, V Kaushal, S Jain, Purvish M Parikh, S Aggarwal
Metastatic breast cancer (MBC) is cancer that has spread from the breast to another part of the body or has come back in another distant location. Treatment options for MBC depend on several factors. One of these factors is the levels of hormone receptors (HRs) in the tumor. Cancers with high levels of HRs, called HR-positive, use the hormones estrogen and progesterone to grow and spread. Hormonal therapy is a type of treatment specifically for HR-positive breast cancer. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at these practical consensus recommendations in regards with the use of hormonal therapy and the management of HR-positive MBC for the benefit of community oncologists...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721480/practical-consensus-recommendations-regarding-the-management-of-sentinel-lymph-node-issues-in-early-breast-cancer
#6
Vedant Kabra, R Aggarwal, S Vardhan, M Singh, R Khandelwal, S Jain, S Sahani, S Saini, N Deo, R Kaul, P M Parikh, S Aggarwal
Axillary lymph node involvement is a very important poor prognostic factor in the clinical staging and management of breast cancer patients. Traditionally, axillary lymph node dissection (ALND) has been used for determining the status of the axillary lymph nodes. More recently the sentinel lymph node biopsy (SLNB) procedure has gained wider acceptance as the standard of care, having the advantage of being less invasivewhile providing good accuracy. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at these practical consensus recommendations in regards with the use of the two different procedures and other issues in patients with early breast cancer for the benefit of community oncologists...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721479/practical-consensus-recommendations-on-management-of-triple-negative-metastatic-breast-cancer
#7
R Rangarao, B K Smruti, K Singh, A Gupta, S Batra, R K Choudhary, A Gupta, S Sahani, Vedant Kabra, Purvish M Parikh, S Aggarwal
Patients with breast cancer along with metastatic estrogen and progesterone receptor (ER/PR)- and human epidermal growth factor receptor 2 (HER2)-negative tumors are referred to as having metastatic triple-negative breast cancer (mTNBC) disease. Resistance to current standard therapies such as anthracyclines or taxanes limits the available options for previously treated patients with metastatic TNBC to a small number of non-cross-resistant regimens, and there is currently no preferred standard chemotherapy...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721478/practical-consensus-recommendations-regarding-the-management-of-hormone-receptor-positive-early-breast-cancer-in-elderly-women
#8
Govind Babu, A Goel, S Agarwal, S Gupta, P Kumar, B K Smruti, V Goel, R Sarangi, M Gairola, S Aggarwal, Purvish M Parikh
Breast cancer is a leading cause of death among women, and its incidence increases with age. Currently the treatment of breast cancer in older patients is almost identical to their younger counterparts. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at these practical consensus recommendations for the benefit of community oncologists regarding the management of early breast cancer specifically in elderly women.
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721477/practical-consensus-recommendations-on-her2-ve-breast-cancer-with-solitary-brain-mets
#9
Nitesh Rohatgi, A Munshi, P Bajpai, M Singh, S Sahai, M Ahmad, K Singh, H Singh, Purvish M Parikh, S Aggarwal
Breast cancer is a common cause of brain metastases, with metastases occurring in at least 10-16% of patients. Longer survival of patients with metastatic breast cancer and the use of better imaging techniques are associated with an increased incidence of brain metastases. Current therapies include surgery, whole-brain radiation therapy, stereotactic radiosurgery, chemotherapy and targeted therapies. However, the timing and appropriate use of these therapies is controversial and careful patient selection by using available prognostic tools is extremely important...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721476/practical-consensus-recommendations-for-gestational-breast-cancer
#10
J S Sekhon, N Naik, P Bansal, I Bansal, A Dhull, A Goel, C S Ramachandran, S Shinde, S Aggarwal, P M Parikh
This manuscript provides a practical and easy to use consensus recommendation to community oncologists on how to manage gestational breast cancer.
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721475/practical-consensus-recommendations-on-fertility-preservation-in-patients-with-breast-cancer
#11
Jyoti Bajpai, A Majumdar, R Satwik, N Rohatgi, V Jain, D Gupta, R Agarwal, S Mittal, S K Verma, P M Parikh, S Aggarwal
Young women diagnosed with cancer today have a greater chance of long-term survival than ever before. Successful survivorship for this group of patients includes maintaining a high quality of life after a cancer diagnosis and treatment; however, lifesaving treatments such as chemotherapy, radiation, and surgery can impact survivors by impairing reproductive and endocrine health. Expert oncologists along with reproductive medicine specialists discuss fertility preservation options in this chapter since fertility preservation is becoming a priority for young women with breast cancer...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721474/practical-consensus-recommendation-on-when-to-do-brca-testing
#12
Purvish M Parikh, J Wadhwa, S Minhas, A Gupta, S Mittal, S Ranjan, P Mehta, R Singh, S P Kataria, S Salim, M Ahmed, S Aggarwal
BRCA -mutation associated breast cancer and to future cancer risks and sensitivity to systemic therapies. Now that rapid genetic testing for BRCA1 and BRCA2 mutations is available, BRCA mutation status can be considered when making treatment and prevention decisions for BRCA testing, BRCA mutation carriers with breast cancer. Expert group used data from published literature, practical experience, and opinion of a large group of academic oncologists, to arrive at practical consensus recommendations for use by the community oncologists...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721473/practical-consensus-recommendations-regarding-the-management-of-her2-neu-positive-early-breast-cancer
#13
A Bahl, R Singh, J Wadhwa, S Gupta, M Ahmed, P N Uppal, Purvish M Parikh, S Aggarwal
Over-expression of HER2 is generally considered to be a negative prognostic feature because it accompanies an increase in breast cancer mortality. However, the development of agents that specifically target HER2 has improved the management of patients with these tumours. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at these practical consensus recommendations with regards to the use of these agents and the management of HER2 neu early breast cancer for the benefit of community oncologists...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721472/practical-consensus-recommendations-on-management-of-hr-ve-early-breast-cancer-with-specific-reference-to-genomic-profiling
#14
S Aggarwal, A Vaid, A Ramesh, Purvish M Parikh, S Purohit, B Avasthi, S Gupta, S Ranjan, V Kaushal, S Salim, R Singh, S Minhas, D Doval
Breast cancer is a heterogeneous disease and patients are managed clinically based on ER, PR, HER2 expression, and key risk factors. The use of gene expression assays for early stage disease is already common practice. These tests have found a place in risk stratifying the heterogeneous group of stage I-II breast cancers for recurrence, for predicting chemotherapy response, and for predicting breast cancer-related mortality. Most guidelines for hormone receptor (HR)-positive early breast cancer recommend addition of adjuvant chemotherapy for most women, leading to overtreatment, which causes considerable morbidity and cost...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721471/practical-consensus-recommendaton-for-adjuvant-bone-modifying-agents-in-breast-cancer
#15
A Bharatuar, M Kar, S Khatri, V Goswami, R Sarin, S Dawood, R Iyenger, M Ganvir, Purvish M Parikh, S Aggarwal, Vineet Talwar
Bone-modifying therapy is a primary research interest in breast cancer. Several features contribute to the importance of the bone environment in the management of breast cancer. Firstly, bone metastases represent the most common site of breast cancer metastases and secondly, the emergence of cancer treatment-induced bone loss (CTIBL) among breast cancer survivors and patients is of increasing concern. In the adjuvant setting, bisphosphonates can be given to prevent and treat tumor therapy-induced bone loss in premenopausal and postmenopausal women and, owing to their beneficial effect on bone turnover, have also been evaluated for prevention of bone metastases occurrence...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721470/practical-consensus-recommendations-regarding-role-of-postmastectomy-radiation-therapy
#16
D Singh, G Saini, R Koul, V Gupta, D Abrol, S De, P Kulshrestha, S N Hukku, S J Lakshmi, Purvish M Parikh, S Aggarwal
The use of radiation therapy after mastectomy (PMRT) has been limited to those patients who are at significant risk of cancer recurring in the chest wall or in the nodal basins. The use of PMRT has been widely accepted for patients with four or more positive lymph nodes,[1],[2] but there is still controversy regarding the value of PMRT for those with one to three positive nodes. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at these practical consensus recommendations for the benefit of community oncologists...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721469/practical-consensus-recommendatons-for-paget-s-disease-in-breast-cancer
#17
A Gaurav, V Gupta, R Koul, S Dabas, R Sareen, K Geeta, V Arora, Purvish M Parikh, S Aggarwal
Paget's disease of the breast is a rare type of cancer of the nipple-areola complex and that is often associated with an underlying in situ or invasive carcinoma. Diagnosis and treatment of Paget's disease is controversial. Expert oncologists discuss on the update on the approaches of Paget's disease diagnosis and its treatment options. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at this practical consensus recommendations for the benefit of community oncologists...
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721468/practical-consensus-recommendations-regarding-role-of-mastectomy-in-metastatic-breast-cancer
#18
S P Somsekhar, K Geeta, R Jain, R Nayyer, S Halder, V K Malik, Purvish Parikh, S Aggarwal, R Koul
Whether to recommend mastectomy in metastatic disease or not has been a matter of debate. Is local therapy, such as mastectomy, of any benefit in advanced breast cancer is the main question. This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at these practical consensus recommendations for the benefit of community oncologists.
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721467/practical-consensus-recommendations-for-tumor-margins-and-breast-conservative-surgery
#19
R Sarin, S P Somsekhar, R Kumar, Gupta Pawan, Jain Sumeet, Jindal Pramoj, Zamre Vaishali, Pasha Firoz, P M Parikh, S Aggarwal, R Koul
My suggestion: There is no difference in survival of breast cancer patients treated with either mastectomy or with breast conservation therapy combined with external beam radiotherapy. A positive margin (s) is an important factor contributing to the increased risk of local recurrence. However, in published literature, there is a lack of consensus on the definition of acceptable margin (s). As a result decision process about need for re-excision after positive margins remains uncrear.
April 2018: South Asian Journal of Cancer
https://www.readbyqxmd.com/read/29721466/role-of-magnetic-resonance-imaging-in-breast-cancer-management
#20
Selvi Radhakrishna, S Agarwal, Purvish M Parikh, K Kaur, Shikha Panwar, Shelly Sharma, Ashish Dey, K K Saxena, Madhavi Chandra, Seema Sud
Magnetic resonance imaging (MRI) of the breast is primarily used as a supplemental tool to breast screening with mammography or ultrasound. A breast MRI is mainly used for women who have been diagnosed with breast cancer, to help measure the size of the cancer, look for other tumors in the breast, and to check for tumors in the opposite breast. For certain women at high risk for breast cancer, a screening MRI is recommended along with a yearly mammogram. MRI is known to give some false positive results which mean more test and/or biopsies for the patient...
April 2018: South Asian Journal of Cancer
journal
journal
48272
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"